aspirin has been researched along with 9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cmiel, A; Dworski, R; Mastalerz, L; Nizankowska, E; Oates, JA; Prokop, A; Sheller, JR; Szczeklik, A | 1 |
Guzzo, C; Lazarus, G; Mitchell, TA; Morrow, JD; Oates, JA; Roberts, LJ; Zackert, WE | 1 |
1 trial(s) available for aspirin and 9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid
Article | Year |
---|---|
Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Aspirin; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Eicosanoids; Eosinophils; Female; Forced Expiratory Volume; Humans; Leukotriene E4; Lysine; Male; Middle Aged; Placebos; Prostaglandin D2; Prostaglandins D; Salmeterol Xinafoate | 1998 |
1 other study(ies) available for aspirin and 9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid
Article | Year |
---|---|
Increased formation of thromboxane in vivo in humans with mastocytosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aspirin; beta-Thromboglobulin; Cyclooxygenase Inhibitors; Female; Humans; Male; Methylhistamines; Middle Aged; Platelet Factor 4; Prostaglandins D; Thromboxane B2; Urticaria Pigmentosa | 1999 |